Arterial stiffness and blood pressure increase in pediatric kidney transplant recipients
C19.CHILD Study Group. Long-Term Antibody Response to SARS-CoV-2 in Children
Chronic liver disease and hepatic calcium-oxalate deposition in patients with primary hyperoxaluria type I
Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy
MR imaging in children with transverse myelitis and acquired demyelinating syndromes
Developmental outcomes in children/adolescents and one adult with tuberous sclerosis complex (TSC) and refractory epilepsy treated with everolimus.
Share Cathepsin D as biomarker in cerebrospinal fluid of nusinersen-treated patients with spinal muscular atrophy.
Multilobar Epilepsy Surgery in Childhood and Adolescence: Predictors of Long-Term Seizure Freedom.
High association of MOG-IgG antibodies in children with bilateral optic neuritis.
Share Treatment with Nusinersen – Challenges Regarding the Indication for Children with SMA Type 1.
Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C.
Share Clinical and Genetic Features in Patients With Reflex Bathing Epilepsy.
Network for Therapy in Rare Epilepsies (NETRE): Lessons From the Past 15 Years.
Long-term treatment with everolimus in TSC-associated therapy-resistant epilepsies.
Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline
Body growth, upper arm fat area, and clinical parameters in children with nephropathic cystinosis compared with other pediatric chronic kidney disease entities
Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS)
Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry.
Commentary on "Pediatric Idiopathic Steroid-sensitive Nephrotic Syndrome Diagnosis and Therapy – Short version of the updated German Best Practice Guideline (S2e)
Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study.
Consensus-based recommendations for the management of juvenile systemic sclerosis.
Under detection of interstitial lung disease in juvenile systemic sclerosis (jSSc).
Treat-to-Target Study for Improved Outcome in Polyarticular Juvenile Idiopathic Arthritis.
Diagnostics and therapy for cutaneous lupus erythematosus. S2K guideline.
Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes.
Bone and Mineral Metabolism in Children with Nephropathic Cystinosis Compared with other CKD Entities.
Evidence-based consensus statements for the identification and management of interstitial lung disease in systemic sclerosis.
Long-term surveillance of biologic therapies in systemic-onset juvenile idiopathic arthritis: data from the German BIKER registry.
Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial.
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis.
Juvenile Idiopathic Arthritis and the Temporomandibular Joint: Prevalence, Risk Factors and Diagnostic Tools.